Cumberland Pharmaceuticals Shares Outstanding 2009-2019 | CPIX

Cumberland Pharmaceuticals shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Cumberland Pharmaceuticals Annual Shares Outstanding (Millions of Shares)
2018	16
2017	16
2016	16
2015	17
2014	18
2013	18
2012	20
2011	21
2010	21
2009	18
2008	17

Cumberland Pharmaceuticals Quarterly Shares Outstanding (Millions of Shares)
Q1 2019	15
Q4 2018	16
Q3 2018	16
Q2 2018	16
Q1 2018	16
Q4 2017	16
Q3 2017	16
Q2 2017	16
Q1 2017	16
Q4 2016	16
Q3 2016	17
Q2 2016	16
Q1 2016	16
Q4 2015	17
Q3 2015	17
Q2 2015	17
Q1 2015	17
Q4 2014	18
Q3 2014	18
Q2 2014	18
Q1 2014	18
Q4 2013	18
Q3 2013	18
Q2 2013	18
Q1 2013	19
Q4 2012	20
Q3 2012	20
Q2 2012	20
Q1 2012	20
Q4 2011	21
Q3 2011	21
Q2 2011	21
Q1 2011	21
Q4 2010	21
Q3 2010	21
Q2 2010	21
Q1 2010	21
Q4 2009	18
Q3 2009	19
Q2 2009	16
Q1 2009	16
Q4 2008	0
Q3 2008	17
Q2 2008	16

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.098B	$0.041B
Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients.

Stock Name	Country	Market Cap	PE Ratio
Zoetis (ZTS)	United States	$54.313B	34.70
Takeda Pharmaceutical (TAK)	Japan	$27.201B	7.99
Grifols (GRFS)	Spain	$13.779B	17.43
Sage Therapeutics (SAGE)	United States	$9.044B	0.00
Ionis Pharmaceuticals (IONS)	United States	$8.958B	19.58
Neurocrine Biosciences (NBIX)	United States	$7.714B	0.00
Catalent (CTLT)	United States	$7.679B	30.82
Jazz Pharmaceuticals (JAZZ)	Ireland	$7.437B	10.19
Nektar Therapeutics (NKTR)	United States	$5.907B	9.63
Tilray (TLRY)	Canada	$4.670B	0.00
FibroGen (FGEN)	United States	$3.751B	0.00
United Therapeutics (UTHR)	United States	$3.332B	0.00
Taro Pharmaceutical Industries (TARO)	Israel	$3.309B	11.61
Arrowhead Pharmaceuticals (ARWR)	United States	$2.607B	392.86
PTC Therapeutics (PTCT)	United States	$2.470B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$1.924B	6.92
Xencor (XNCR)	United States	$1.909B	52.11
Portola Pharmaceuticals (PTLA)	United States	$1.796B	0.00
Pacira Pharmaceuticals (PCRX)	United States	$1.781B	86.24
Zogenix (ZGNX)	United States	$1.730B	0.00
Tricida (TCDA)	United States	$1.720B	0.00
USANA Health Sciences (USNA)	United States	$1.688B	14.67
Enanta Pharmaceuticals (ENTA)	United States	$1.630B	22.28
Ironwood Pharmaceuticals (IRWD)	United States	$1.590B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$1.557B	0.00
Heron Therapeutics (HRTX)	United States	$1.406B	0.00
Aerie Pharmaceuticals (AERI)	United States	$1.387B	0.00
Turning Point Therapeutics (TPTX)	United States	$1.322B	0.00
Esperion Therapeutics (ESPR)	United States	$1.309B	0.00
Corcept Therapeutics (CORT)	United States	$1.190B	16.98
ArQule (ARQL)	United States	$1.094B	0.00
Radius Health (RDUS)	United States	$1.078B	0.00
Spectrum Pharmaceuticals (SPPI)	United States	$0.916B	0.00
Theravance Biopharma (TBPH)	Cayman Islands	$0.899B	0.00
Endo (ENDP)	Ireland	$0.812B	1.31
Aptorum Group (APM)	China	$0.755B	0.00
Odonate Therapeutics (ODT)	United States	$0.751B	0.00
CannTrust Holdings (CTST)	Canada	$0.706B	0.00
Organogenesis Holdings (ORGO)	United States	$0.658B	0.00
Translate Bio (TBIO)	United States	$0.638B	0.00
TherapeuticsMD (TXMD)	United States	$0.603B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$0.573B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$0.567B	0.00
Dermira (DERM)	United States	$0.510B	0.00
Akebia Therapeutics (AKBA)	United States	$0.502B	0.00
ChemoCentryx (CCXI)	United States	$0.495B	0.00
GlycoMimetics (GLYC)	United States	$0.485B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.459B	0.00
Siga Technologies (SIGA)	United States	$0.450B	1.06
BioSpecifics Technologies Corp (BSTC)	United States	$0.420B	21.18
Flexion Therapeutics (FLXN)	United States	$0.414B	0.00
Collegium Pharmaceutical (COLL)	United States	$0.414B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$0.400B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.386B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$0.371B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.370B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.367B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.349B	0.00
TCR2 Therapeutics (TCRR)	United States	$0.349B	0.00
Rafael Holdings (RFL)	United States	$0.334B	0.00
Forty Seven (FTSV)	United States	$0.333B	0.00
Harpoon Therapeutics (HARP)	United States	$0.309B	0.00
Molecular Templates (MTEM)	United States	$0.299B	0.00
OptiNose (OPTN)	United States	$0.298B	0.00
Xeris Pharmaceuticals (XERS)	United States	$0.291B	0.00
CASI Pharmaceuticals (CASI)	United States	$0.290B	0.00
ImmunoGen (IMGN)	United States	$0.280B	0.00
Concert Pharmaceuticals (CNCE)	United States	$0.271B	0.00
Dova Pharmaceuticals (DOVA)	United States	$0.264B	0.00
Aratana Therapeutics (PETX)	United States	$0.246B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.238B	0.00
Minerva Neurosciences (NERV)	United States	$0.231B	0.00
La Jolla Pharmaceutical (LJPC)	United States	$0.225B	0.00
Lannett Co Inc (LCI)	United States	$0.222B	2.15
Recro Pharma (REPH)	United States	$0.215B	0.00
Marinus Pharmaceuticals (MRNS)	United States	$0.200B	0.00
ASSERTIO THERAPEUTICS, INC (ASRT)	United States	$0.196B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.195B	0.00
Opexa Therapeutics (ACER)	United States	$0.194B	0.00
Bio Blast Pharma (ENLV)	Israel	$0.188B	0.00
Galectin Therapeutics (GALT)	United States	$0.187B	0.00
Ocular Therapeutix (OCUL)	United States	$0.187B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.184B	0.00
MEI Pharma (MEIP)	United States	$0.183B	0.00
AcelRx Pharmaceuticals (ACRX)	United States	$0.182B	0.00
Taiwan Liposome, Unsponsored ADR (TLC)	Taiwan	$0.169B	0.00
Nature's Sunshine Products (NATR)	United States	$0.160B	51.88
Ardelyx (ARDX)	United States	$0.159B	0.00
Calithera Biosciences (CALA)	United States	$0.152B	0.00
Redhill Biopharma (RDHL)	Israel	$0.150B	0.00
IMV INC (IMV)	Canada	$0.148B	0.00
AgeX Therapeutics (AGE)	United States	$0.148B	0.00
Jounce Therapeutics (JNCE)	United States	$0.147B	0.00
Foamix Pharmaceuticals (FOMX)	Israel	$0.141B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.140B	0.00
Majesco Entertainment (PTE)	United States	$0.138B	0.00
Neon Therapeutics (NTGN)	United States	$0.131B	0.00
Matinas Biopharma Holdings (MTNB)	United States	$0.116B	0.00
Tyme Technologies (TYME)	United States	$0.114B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$0.103B	0.00
DURECT (DRRX)	United States	$0.102B	0.00
Aquestive Therapeutics (AQST)	United States	$0.101B	0.00
Avenue Therapeutics (ATXI)	United States	$0.100B	0.00
Bellicum Pharmaceuticals (BLCM)	United States	$0.097B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.096B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.094B	0.00
Champions Oncology (CSBR)	United States	$0.094B	0.00
Infinity Pharmaceuticals (INFI)	United States	$0.092B	0.00
Mast Therapeutics (SVRA)	United States	$0.092B	0.00
Cardiome Pharma (CORV)	Canada	$0.092B	0.00
MediWound (MDWD)	Israel	$0.088B	0.00
Natural Alternatives (NAII)	United States	$0.088B	8.80
Nivalis Therapeutics (ALPN)	United States	$0.084B	0.00
India Globalization Capital (IGC)	United States	$0.081B	0.00
Capnia (SLNO)	United States	$0.079B	0.00
Entasis Therapeutics Holdings (ETTX)	United States	$0.079B	0.00
Otonomy (OTIC)	United States	$0.079B	0.00
Adherex Technologies (FENC)	United States	$0.078B	0.00
Novan (NOVN)	United States	$0.072B	0.00
Melinta Therapeutics (MLNT)	United States	$0.069B	0.00
SCYNEXIS (SCYX)	United States	$0.069B	0.00
Adamis Pharmaceuticals (ADMP)	United States	$0.060B	0.00
Neos Therapeutics (NEOS)	United States	$0.058B	0.00
CTI BioPharma (CTIC)	United States	$0.056B	0.00
ElectroCore (ECOR)	United States	$0.056B	0.00
Dipexium Pharmaceuticals (PLXP)	United States	$0.055B	0.00
Opiant Pharmaceuticals (OPNT)	United States	$0.054B	0.00
Genocea Biosciences (GNCA)	United States	$0.051B	0.00
Zafgen (ZFGN)	United States	$0.049B	0.00
ProNAi Therapeutics (SRRA)	Canada	$0.046B	0.00
AIT Therapeutics (AITB)	Israel	$0.046B	0.00
Forward Pharma (FWP)	Denmark	$0.046B	0.00
Ampio Pharmaceuticals (AMPE)	United States	$0.045B	0.00
KemPharm (KMPH)	United States	$0.044B	0.00
Lipocine (LPCN)	United States	$0.043B	0.00
BioLineRx (BLRX)	Israel	$0.043B	0.00
Actinium Pharmaceuticals (ATNM)	United States	$0.042B	0.00
Mannatechorporated (MTEX)	United States	$0.040B	0.00
ContraFect (CFRX)	United States	$0.039B	0.00
Bio-Path Holdings (BPTH)	United States	$0.037B	0.00
NovaBay Pharmaceuticals (NBY)	United States	$0.035B	0.00
ProPhase Labs (PRPH)	United States	$0.033B	0.00
Tetraphase Pharmaceuticals (TTPH)	United States	$0.032B	0.00
PharmAthene (ALT)	United States	$0.030B	0.00
IsoRay (ISR)	United States	$0.028B	0.00
Heat Biologics (HTBX)	United States	$0.025B	0.00
Zomedica Pharmaceuticals (ZOM)	United States	$0.025B	0.00
Regulus Therapeutics (RGLS)	United States	$0.025B	0.00
GTx (ONCT)	United States	$0.025B	0.00
Biomerica (BMRA)	United States	$0.024B	0.00
Pain Therapeutics (SAVA)	United States	$0.023B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.023B	0.00
Onconova Therapeutics (ONTX)	United States	$0.022B	0.00
Summit Therapeutics (SMMT)	United Kingdom	$0.020B	1.64
CollPlant Holdings Sponsored ADR (CLGN)	Israel	$0.019B	0.00
Cyanotech (CYAN)	United States	$0.018B	0.00
NanoViricides (NNVC)	United States	$0.018B	0.00
Shineco (TYHT)	China	$0.016B	0.00
Achieve Life Sciences (ACHV)	United States	$0.014B	0.00
ESSA Pharma (EPIX)	Canada	$0.014B	0.00
HANCOCK JAFFE (HJLI)	United States	$0.014B	0.00
Kitov Pharmaceuticals Holdings (KTOV)	Israel	$0.014B	0.00
Tokai Pharmaceuticals (NVUS)	United States	$0.013B	0.00
VAXART, INC (VXRT)	United States	$0.012B	0.00
Eyegate Pharmaceuticals (EYEG)	United States	$0.011B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.011B	1.81
Ohr Pharmaceuticals (OHRP)	United States	$0.010B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.010B	0.00
Trillium Therapeutics (TRIL)	Canada	$0.010B	0.00
RXi Pharmaceuticals (PHIO)	United States	$0.009B	0.00
Ritter Pharmaceuticals (RTTR)	United States	$0.008B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.008B	0.00
Xenetic Biosciences (XBIO)	United States	$0.007B	0.00
Jaguar Animal Health (JAGX)	United States	$0.007B	0.00
Auris Medical Holding AG (EARS)	Switzerland	$0.005B	0.00
Midatech Pharma (MTP)	United Kingdom	$0.004B	0.00
DelMar Pharmaceuticals (DMPI)	Canada	$0.004B	0.00
Can-Fite Biopharma (CANF)	Israel	$0.004B	0.00
Advanced Accelerator Applications (AAAP)	France	$0.000B	0.00
Oasmia Pharmaceutical AB (OASM)	Sweden	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00